EXAS Company Profile and Key Details
Exact Sciences Corporation
EXAS Stock Price Chart
Stock Price Today
Exact Sciences Corporation (EXAS) stock declined over -1.38%, trading at $53.53 on NASDAQ, down from the previous close of $54.28. The stock opened at $54.32, fluctuating between $52.43 and $54.88 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Company Information
| Employees | 6500 |
| Beta | 1.27 |
| Sales or Revenue | $2.50B |
| 5Y Sales Change% | 2.731% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
Frequently Asked Questions
Exact Sciences Corporation (NASDAQ: EXAS) stock price is $53.53 in the last trading session. During the trading session, EXAS stock reached the peak price of $54.88 while $52.43 was the lowest point it dropped to. The percentage change in EXAS stock occurred in the recent session was -1.38% while the dollar amount for the price change in EXAS stock was -$0.75.
The NASDAQ listed EXAS is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Exact Sciences Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
James Herriott
Senior Vice President, Gen. Counsel & Sec.
Mr. Everett V. Cunningham
Chief Commercial Officer
Mr. Tim Caprez
Chief Compliance Counsel & Vice President
Ms. Megan Jones
Associate Mang. of Investor Relations
Mr. Kevin T. Conroy
Chairman of The Board & Chief Executive Officer
Mr. D. Scott Coward
Chief Legal Officer
Mr. Graham P. Lidgard
Emeritus Chief Science Officer
Ms. Sarah Condella
Executive Vice President of HR
Mr. Vic Parker
Head of Sales
Dr. Jorge A. Garces Ph.D.
Chief Science Officer
Mr. Sri Kalluri
Chief Information Officer
Mr. James Herriott
Senior Vice President, Gen. Counsel & Sec.
Ms. Kristen Weiler
Vice President of Marketing
Mr. Jeffrey T. Elliott CFA
Executive Vice President & Chief Financial Officer
EXAS's closing price is 31.78% higher than its 52-week low of $40.62 where as its distance from 52-week high of $79.62 is -32.77%.
Number of EXAS employees currently stands at 6,500.
Official Website of EXAS is: https://www.exactsciences.com
EXAS could be contacted at phone 608 284 5700 and can also be accessed through its website. EXAS operates from 5505 Endeavor Lane, Madison, WI 53719, United States.
EXAS stock volume for the day was 1.72M shares. The average number of EXAS shares traded daily for last 3 months was 2.34M.
The market value of EXAS currently stands at $9.91B with its latest stock price at $53.53 and 185.08M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com